Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo

Experimental Neurology

Volumn 163, Issue 2, 2000, Pages 388-391

  Sheng, J G ^a,e   Zhu, S G ^f   Jones, R A ^a   Griffin, W S T ^a,c   Mrak, R E ^b,d  

^a John L McClellan Mem Vet' Aff M ^*  (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Department of Geriatric   (United States)

^d John L McClellan Mem Vet' Aff M   (United States)

^e SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^f JILIN UNIVERSITY   (China)

Author keywords

Hyperphosphorylation; Interleukin 1; Neurofibrillary tangles; Neurofilaments; Tau

Indexed keywords

INTERLEUKIN 1; MICROTUBULE ASSOCIATED PROTEIN; TAU PROTEIN;

ANIMAL CELL; ARTICLE; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IMPLANTATION; IN VIVO STUDY; MICROTUBULE ASSEMBLY; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NONHUMAN; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PHOSPHORYLATION; RAT;

EID: 0034042595     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7393     Document Type: Article

References (18)

1. Chambers C. B., Muma N. A. Tau mRNA isoforms following sciatic nerve axotomy with and without regeneration. Mol. Brain Res. 48:1997;115-124.
2. Dinarello C. A., Wolff S. M. The role of interleukin-1 in disease. N. Engl. J. Med. 328:1993;106-113.
3. Feany M. B., Dickson D. W. Neurodegenerative disorders with extensive tau pathology: A comparative study and review. Ann. Neurol. 40:1996;139-148.
4. Griffin W. S. T., Sheng J. G., Roberts G. W., Mrak R. E. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54:1995;276-281.
5. Griffin W. S. T., Sheng J. G., Mrak R. E. Senescence-accelerated overexpression of S100β in brain of SAMP6 mice. Neurobiol. Aging. 19:1998;71-76.
6. Griffin W. S. T., Sheng J. G., Royston M. C., Gentleman S. M., Graham D. I., Roberts G. W., Mrak R. E. Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'cytokine cycle' in disease progression. Brain. Pathol. 8:1998;65-72.
7. Griffin W. S. T., Stanley L. C., Ling C., White L., Macleod V., Perrot L. J., White C. L. III, Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
8. Guan Z., Tetsuka T., Baier L. D., Morrison A. R. Interleukin-1 beta activates c-jun NH2-terminal kinase subgroup of mitogen-activated protein kinases in mesangial cells. Am. J. Physiol. 270:1966;F634-F641.
9. Guy G. R., Cairns J., Ng S. B., Tan Y. H. Inactivation of a redox-sensitive protein phosphatase during the early events of tumor necrosis factor/interleukin-1 signal transduction. J. Biol. Chem. 268:1993;2141-2148.
10. Li Y., Liu L., Kang J., Sheng J. G., Barger S. W., Mrak R. E., Griffin W. S. T. Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J. Neurosci. 20:2000;149-155.
11. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Yoshida H., Watanabe A., Titani K., Ihara Y. Hyperphosphorylation of tau in PHF. Neurobiol. Aging. 16:1995;365-371.
12. Mrak R. E., Sheng J. G., Griffin W. S. T. Glial cytokines in Alzheimer's disease. Review and pathogenic implications. Hum. Pathol. 226:1995;816-823.
13. O'Neill L. A. J. Towards an understanding of the signal transduction pathways for interleukin 1. Biochim. Biophys. Acta. 1266:1995;31-44.
14. Rothwell N. J. Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol. Sci. 12:1991;430-436.
15. + astrocytes with neurofibrillary tangle stages. J. Neuropathol. Exp. Neurol. 56:1997;285-290.
16. Sheng J. G., Ito K., Skinner R. D., Mrak R. E., Rovnaghi C. R., Van Eldik L. J., Griffin W. S. T. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging. 17:1996;761-766.
17. Su J. H., Cummings B. J., Cotman C. W. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments. Brain Res. 793:1996;79-87.
18. Vawter M. P., Basaric-Keys J., Li Y., Lester D. S., Lebovics R. S., Lesch K. P., Kulaga H., Freed W. J., Sunderland T., Wolozin B. Human olfactory neuroepithelial cells: Tyrosine phosphorylation and process extension are increased by the combination of IL-1β, IL-6, NGF, and bFGF. Exp. Neurol. 142:1996;179-194.